“We are pleased to welcome Jane Buus Laursen to Camurus as Chief Corporate Development Officer. Jane will have a central role in the company with responsibility for strategic development towards new growth targets, expansion and long-term value creation, together with the executive management”, says Fredrik Tiberg, Camurus’ President and CEO. “Jane offers significant experience from senior positions at leading pharmaceutical companies and joins Camurus during ongoing growth and expansion.”

Jane Buus Laursen

Jane brings more than 20 years of experience from senior positions at Novo Nordisk and AstraZeneca within Business and Corporate Development, with a strong track record of driving strategic licensing and M&A transactions, integration processes and alliance management. Most recently, she had the position as Corporate VP in Global Business Development at Novo Nordisk. Jane holds a PhD in Organic & Medicinal chemistry from the Technical University of Denmark (DTU) and the University of Kansas, US, and has a background as senior scientist.

“I am excited to join Camurus at a pivotal point of its growth, with strong momentum and opportunity ahead. I am highly motivated by the strong science-driven and agile culture and clear focus on improving patients’ lives. I look forward to working closely with Fredrik, the executive management, and colleagues across the organization, to develop and implement Camurus’ strategic priorities for long-term growth”, says Jane Buus Laursen.